Interim 2018/19 influenza vaccine effectiveness: six European studies, October 2018 to January 2019. by Kissling, E, Rose, A, Emborg, H, Gherasim, A, Pebody, R, Pozo, F, Trebbien, R, Mazagatos, C, Whitaker, H, Valenciano, M, European IVE Group

Interim 2017/18 influenza seasonal vaccine effectiveness: combined results from five European studies by Rondy, M, Kissling, E, Emborg, H, Gherasim, A, Pebody, R, Trebbien, R, Pozo, F, Larrauri, A, McMenamin, J, Valenciano, M, I-Move/I-Move+ Group

Estimating transmission parameters for respiratory syncytial virus and predicting the impact of maternal and pediatric vaccination by Van Boven, M, Teirlinck, AC, Meijer, A, Hooiveld, M, Van Dorp, CH, Reeves, RM, Campbell, H, Van Der Hoek, W, Reeves, RM, Li, Y, Campbell, H, Nair, H, Van Wijhe, M, Fischer, TK, Simonsen, L, Trebbien, R, Tong, S, Gallichan, S, Bangert, M, Demont, C, Lehtonen, T, Heikkinen, T, Teirlinck, A, Van Boven, M, Van Der Hoek, W, Van Der Maas, N, Meijer, A, Fernandez, LV, Bøas, H, Bekkevold, T, Flem, E, Stona, L, Speltra, I, Giaquinto, C, Cheret, A, Leach, A, Stoszek, S, Beutels, P, Bont, L, Pollard, A, Openshaw, P, Abram, M, Swanson, K, Rosen, B, Molero, E